Letter to the Editor
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 16, 2023; 11(2): 479-481
Published online Jan 16, 2023. doi: 10.12998/wjcc.v11.i2.479
Incidence and clinical treatment of hypertriglyceridemic acute pancreatitis: A few issues
Qun-Ying Yang, Qian Zhao, Jian-Wen Hu
Qun-Ying Yang, Qian Zhao, Jian-Wen Hu, Department of Gastroenterology, Dongyang People's Hospital, Dongyang 322100, Zhejiang Province, China
Author contributions: Yang QY and Zhao Q reviewed the literature and contributed to manuscript drafting; Hu JW was responsible for the revision of the manuscript for important intellectual content; All authors reviewed and approved the final version.
Conflict-of-interest statement: The authors have no conflicts of interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jian-Wen Hu, PhD, Professor, Department of Gastroenterology, Dongyang People's Hospital, No. 60 Wuning West Road, Dongyang 322100, Zhejiang Province, China. cchcsq0529@163.com
Received: September 22, 2022
Peer-review started: September 22, 2022
First decision: November 5, 2022
Revised: November 16, 2022
Accepted: January 3, 2023
Article in press: January 3, 2023
Published online: January 16, 2023
Processing time: 111 Days and 19.8 Hours
Core Tip

Core Tip: This is a comment on an article concerning the incidence and clinical characteristics of hypertriglyceridemic acute pancreatitis (HTG-AP). We believe that the risk of hypoglycemia must be considered and described for non-diabetic patients with HTG-AP receiving insulin infusion to decrease serum triglyceride level.